Vaping Does NOT Typically Cause Polycythemia Like Traditional Cigarettes
While traditional cigarette smoking causes true polycythemia through chronic carbon monoxide exposure, current evidence suggests vaping does not produce the same mechanism or degree of erythrocytosis, though rare case reports exist.
Understanding the Mechanism Difference
Traditional smoker's polycythemia is well-established and occurs through a specific pathway: chronic carbon monoxide exposure from combustible tobacco triggers compensatory erythropoietin (EPO) production, leading to true secondary polycythemia that resolves with smoking cessation 1. This is a hypoxia-driven process where carbon monoxide binds hemoglobin, creating tissue hypoxia that stimulates red blood cell production.
E-cigarettes fundamentally differ because they do not produce carbon monoxide through combustion 2. Instead, they heat liquid containing nicotine, propylene glycol, glycerin, and flavorings to produce an aerosol—avoiding the primary mechanism that causes smoker's polycythemia.
The Limited Case Report Evidence
Only two isolated case reports document vaping-associated erythrocytosis:
- A 2019 case described a 71-year-old man who developed polycythemia after switching from 50 pack-years of traditional cigarettes to e-cigarettes, with normalization after vaping cessation 3
- A 2026 case reported a young man with vaping-induced erythrocytosis that resolved with cessation 4
These represent extraordinarily rare occurrences given the millions of vapers worldwide. The 2019 case is particularly difficult to interpret—the patient had 50 years of heavy smoking history, making it unclear whether residual effects from traditional smoking or other factors contributed.
Population-Level Data Shows Different Hematologic Effects
A large cross-sectional NHANES study (2013-2018, n=17,180) examined whole blood cell parameters in vapers versus non-smokers 5. Vapers showed increased white blood cells (particularly lymphocytes and monocytes) and slightly elevated mean cell volume (MCV) and mean cell hemoglobin (MCH) compared to non-smokers, but this represents inflammatory changes rather than true polycythemia. These findings suggest systemic inflammation, not the compensatory erythrocytosis seen with carbon monoxide exposure.
Clinical Implications and Workup
When encountering erythrocytosis in a vaper:
First, exclude traditional smoking history and other common causes:
- Verify no concurrent or recent traditional cigarette use
- Assess for hypoxic conditions (sleep apnea, chronic lung disease, high altitude)
- Rule out dehydration/relative polycythemia
- Check for medications or supplements (testosterone, EPO)
- Evaluate for renal lesions or other EPO-secreting tumors
Second, consider primary polycythemia vera:
- Check JAK2 V617F mutation (positive in >95% of PV cases) 6
- Measure serum EPO level (typically low-normal in PV, elevated in secondary causes)
- Assess for splenomegaly, thrombocytosis, leukocytosis
Third, if vaping is the only identifiable factor:
- Trial cessation of vaping with serial hematocrit monitoring
- If hematocrit normalizes over 2-3 months, vaping was likely contributory
- If persistent, complete secondary polycythemia workup
Important Caveats
The absence of carbon monoxide does not mean e-cigarettes are harmless. They cause endothelial dysfunction, oxidative stress, and inflammatory changes 7, 8, 9. Nicotine itself has significant cardiovascular effects and can induce cardiac ischemia in patients with coronary artery disease 8. However, these mechanisms do not produce the compensatory erythrocytosis characteristic of traditional smoking.
Dual users (vaping plus traditional cigarettes) maintain the carbon monoxide exposure and would be expected to have smoker's polycythemia from the combustible component 2.
Bottom Line for Clinical Practice
Do not routinely expect or screen for polycythemia in vapers as you would in traditional smokers. The pathophysiologic mechanism (carbon monoxide-induced hypoxia) is absent. If erythrocytosis is present, conduct a thorough evaluation for other causes rather than attributing it to vaping based on the current evidence. The two case reports represent medical curiosities rather than an established clinical pattern, and the mechanism remains unexplained and likely multifactorial in those rare instances.